Si le médicament contre le cholestérol le moins cher était chaque fois prescrit, la sécurité sociale gagnerait 140 millions d’euros. Et les patients 15 millions.
Lisez l'article dans LLB ici.
Subscribe to:
Post Comments (Atom)
skip to main |
skip to sidebar
Followers
Blog Archive
About Me
- Brieuc Van Damme
- I am a young economist at the Itinera Institute, a Brussels based think-tank for sustained economic growth and social protection, and an independent consultant. Since September 2010 I teach "The Contemporary American Economy" class of the M.A. Program in American Studies at the University of Antwerp. I hold degrees in economics from the KULeuven and the College of Europe, and I am an IHS (George Mason University, Virginia) alumnus. My areas of interest (and expertise?) are the political economy in general, and social security systems and healthcare economics in particular. I publish, give lectures and participate in debates in professional and policy circles, as well as in the media.
No comments:
Post a Comment